The establishment of a large collaborative trial programme in the adjuvant treatment of colon cancer

British Journal of Cancer

Volumn 77, Issue SUPPL. 2, 1998, Pages 23-28

  Wils, J ^a  

^a LAURENTIUS HOSPITAL   (Netherlands)

Author keywords

Adjuvant treatment; Colon adenocarcinoma; Mayo regimen; Pan European Trial for Adjuvant Treatment of Colon Cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; RALTITREXED;

ADJUVANT CHEMOTHERAPY; ALOPECIA; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; CONTINUOUS INFUSION; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOXICITY; HUMAN; LEUKOPENIA; MUCOSA INFLAMMATION; PRIORITY JOURNAL;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; EUROPE; HUMANS; IMMUNOTHERAPY; MULTICENTER STUDIES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 0031935180     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.422     Document Type: Article

References (25)

1. Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903
2. Blackledge G (1998) New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex'). Br J Cancer (this suppl.)
3. Bleiberg H (1997) Colorectal cancer: is there an alternative to 5-FU? Eur J Cancer 33: 536-541
4. Boring CC, Squires TS, Tong T and Montgomery S (1994) Cancer Statistics, 1994. CA Cancer J Clin 44: 7-26
5. Coperchini ML and Zalcberg J (1994-95) Overview of the current treatment of colorectal cancer. Diagn Oncol 4: 130-139
6. Estève J, Kricker A, Ferlay J and Parkin DM (1993) In Facts and Figures of Cancer in the European Community. International Agency for Research on Cancer: Lyon
7. Haller DG, Catalano PJ, Macdonald JS and Mayer RJ (1996) Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: preliminary results of INT-0089 (abstract 486). Proc Am Soc Clin Oncol 15: 211a
8. Haller DG, Catalano PJ, Macdonald JS and Mayer RJ (1997) Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: four-year results of INT-0089 (abstract 940). Proc Am Soc Clin Oncol 16: 265a
9. International Multicentre Pooled Analysis of Colon Cancer Trials Investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939-944
10. Kerr DJ (1997) Clinical efficacy of 'Tomudex' (raltitrexed) in advanced colorectal cancer. Anticancer Drugs 8 (suppl. 2): S11-S15
11. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gersmer JB, Krook JE, Malliard J, Twito DI, Morton RF, Tschetter LK and Barlow JF (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil: the North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7: 1447-1456
12. Machover D, Goldsmith E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke J-M, Misset J-L, Schwarzenberg L, Fourtillan JB, Gaget H and Mathé G (1986) Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high dose folinic acid. J Clin Oncol 4: 685-696
13. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH and Mailliard JA (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 8: 352-358
14. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH and Mailliard JA (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122: 321-326
15. National Institutes of Health Consensus Development Conference Statement, April 16-18 (1990) Adjuvant Therapy for Patients with Colon Cancer and Rectum Cancer. Office of Medical Applications of Research. National Institutes of Health: Bethesda, MD
16. O'Connell M, Laurie JA, Shepherd L, Kahn MJ, Pazdur R, Fitzgibbons RJ, Erlichman C and Wieand HS (1996) A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for high-risk colon cancer: a collaborative trial of the North Central Cancer Treatment Group and the National Cancer Institute of Canada trials (abstract 478). Proc Am Soc Clin Oncol 15: 209a
17. O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ and Wieand HS (1997) Controlled trial of flurorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15: 246-250
18. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ and Mittelman A (1987) A prospective randomized clinical trial of 5-fluorouracil versus 5-fluorouracil and high dose leucovorin versus fluorouracil and methotrexate in previously untreated patients with advanced colorectal cancer. J Clin Oncol 5: 1559-1565
19. Petrelli N, Douglas Jr HO, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD and Muggia FM (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 7: 1419-1426
20. Poon MA, O'Connell MJ, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK and Wiesenfeld M (1989) Biochemical modulation of fluorouracil: evidence of significant improvements in survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7: 1407-1418
21. Sobrero AF, Aschele C and Bertino JR (1997) Fluorouracil in colorectal cancer - a tale of two drugs: implications for biochemical modulation. J Clin Oncol 15: 368-381
22. van Triest B, van Groeningen CJ and Pinedo HM (1995) Current chemotherapeutic possibilities in the treatment of colorectal cancer. Eur J Cancer 7/8: 1193-1197
23. Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, Jones J, Glass A, Lerner H and Lawrence W (1988) Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 80: 30-36
24. Wolmark N, Rockette H, Mamounas EP, Jones J, Petrelli N, Atkins J, Dimitrov N, Pugh R, Wickerham DL, Wieand HS and Fisher B (1996) The relative efficacy of 5-FU + leucovorin (FU-LV), 5-FU + levamisole (FU-LEV), and 5-FU + leucovorin + levamisole (FU-LV-LEV) in patients with Dukes' B and C carcinoma of the colon: first report of NSABP C-04 (abstract 460). Proc Am Soc Clin Oncol 15: 205a
25. Zalcberg JR (1997) Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancer. Anti-Cancer Drugs 8(suppl.2):S17-S22